About once each year or two, I try to schedule what I call a “big picture” lab meeting where my lab and I discuss major issues related to being a scientist. Also, I try to answer their questions about just about anything. In my lab we rotate between various lab meeting formats and also have […]
The big picture lab meeting: ethics, careers, publishing & other questions Read More »
In this post I propose that researchers and patients advocate together to pressure the stem cell clinic industry to collect and publish such data. Why do I make such a proposal? Many thousands of patients have bought stem cell interventions from non-compliant stem cell clinics. Thousands of others are considering doing so. You can see
Call to patients: let’s advocate together for stem cell clinic publishing Read More »
Open access publishing is getting a lot of attention. Taxpayer supported government grants + scientists’ work = closed access publisher profits (derived from payments from taxpayers + scientists) This simple equation embodies all that is wrong with today’s predominant system of publishing. In fact, it is an indictment of closed access publishers. The profits of
The case for open access publishing embodied in a single equation Read More »
I took a poll of my blog readers on how strongly they feel about open access. Is open access more than a buzzword? Are scientists willing to go beyond talk and take actions? If the results of the poll are any indication the message is that most scientists are indeed changing their publishing habits to
Are scientists willing to take action for open access publishing? See our poll results Read More »
I have posted before about publishing trends in the iPS cell field here and in here…. but where do things stand today? Here, I provide an important update. What’s going on now? Here I provide answers to the key questions. How many papers are there on iPS cells? An interesting and unexpected trend for
Everything you need to know about publishing in the iPS cell field Read More »
Update in 2020: Wow, a lot has changed since this post almost 10 years ago, but Cell Stem Cell remains the main publisher of IPS cell articles still. The young iPSC field has published a truly massive number of papers in just 4 years. Searching ISI Web of Knowledge for papers with titles reflecting iPSC
Striking iPS cell research publishing trends: what do they mean? Read More »
As we look to 2025, what are the best regenerative medicine and stem cell journals? Is there a stem cell journal list out there? I seem to have the only comprehensive list. Who better than a stem cell biologist to put together this kind of list? Why is this important? Scientists need to know what
List of regenerative medicine & stem cell journals Read More »
Some of you might remember the stem cell clinic firm R3 Stem Cell. I have major concerns about some of what they are marketing including in the U.S. I was reminded of R3 Stem Cell again just now. The Associated Press (AP) ran a PR on R3 Stem like it was a news story. I
Media like the AP promote unproven stem cell clinics such as R3 Stem Cell Read More »
Can researchers use CAR-T for lupus? It’s always exciting when one’s home institution has an interesting new therapy in development. Here at UC Davis Health, there has been an increasing stream of such encouraging trials in the pipeline. I’ve written before about the promising trial of stem cells for spina bifida. Now there’s news related
Recommended reads: CAR-T for Lupus, CRISPR vision, journal closures Read More »
What happens during brain aging and how can we tell if dementia is coming? Are there particular early hallmarks? There are an increasing number of medical tests for predicting or detecting dementia. Alzheimer’s disease can often be detected early. But what do patients or their doctors do with such information? Until recently there weren’t any
Weekly reads: brain aging, perinatal stem cell clinics, $1M lab meat fine bill Read More »